Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumorsGiampiero Giovacchini, Guillaume Nicolas, Flavio Forrer
Current Radiopharmaceuticals|December 31, 2016
Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate CancerGiampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato, et al.
Current Radiopharmaceuticals|November 2, 2017
PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical ImplicationsGiampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato, et al.
Current Radiopharmaceuticals|August 18, 2017
PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical PerspectivesGiampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato, et al.
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Targeted radiotherapy with radiolabeled somatostatin analogsGuillaume Nicolas, Giampiero Giovacchini, Jan Müller-Brand, et al.
Annals of Nuclear Medicine|June 9, 2026
Assessing metabolic progression in temporal lobe epilepsy: biological and methodological considerationsGiampiero Giovacchini, Shubhi Agrawal, Andrea Marciano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsyGiampiero Giovacchini, Shielah Conant, Peter Herscovitch, et al.
Epilepsy Research|May 18, 2026
Is temporal lobe epilepsy a progressive disease? Insights from a 5-HT1A receptor partial volume correction studyGiampiero Giovacchini, Andrea Marciano, Shubhi Agrawal, et al.
Journal of Clinical Medicine|May 27, 2023
Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CTFrancesca Tutino, Elisabetta Giovannini, Silvia Chiola, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 15, 2017
PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studiesGiampiero Giovacchini, Elisabetta Giovannini, Rossella Leoncini, et al.
Pageof 7